Company Presentation
Management — NMD Pharma
Company Presentation
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
Event: Aarhus - Brew Your Own: Meet the founders - Biopeople
NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Management — NMD Pharma
Nmd Pharma A/S, Aarhus N | firma | krak.dk
Management — NMD Pharma
NMD Pharma brænder 41 mio. kr. af sin kæmpeinvestering
NMD Pharma - Capnova
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
Investors — NMD Pharma
Big deal: NMD flexes series A muscles - Global University Venturing
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Nmd Pharma A/S, Aarhus N | firma | krak.dk
Contact — NMD Pharma
NMD bags €38M to run orphan neuromuscular disease trials | FierceBiotech
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
